Pfizer, an American multinational pharmaceutical company, has started phase 1 and 2 clinical trials on their mRNA vaccine candidate today. They are reportedly developing this vaccine in collaboration with BioNtech, a German biotech company. First Post
Wednesday, May 6, 2020
COVID-19 Vaccine: Italy's candidate showed potential in human cells, Pfizer's candidate starts human trials today
Pfizer, an American multinational pharmaceutical company, has started phase 1 and 2 clinical trials on their mRNA vaccine candidate today. They are reportedly developing this vaccine in collaboration with BioNtech, a German biotech company. First Post
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment